Cargando…

Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan

BACKGROUND: Globally metronidazole and carbapenem resistance in anaerobic organisms is increasing necessitating continuous surveillance to guide selection of empirical treatment. In this study we have determined metronidazole resistance in anaerobes using MIC Evaluator strips (M.I.C.E strips). Carba...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafquat, Yusra, Jabeen, Kauser, Farooqi, Joveria, Mehmood, Kiran, Irfan, Seema, Hasan, Rumina, Zafar, Afia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567479/
https://www.ncbi.nlm.nih.gov/pubmed/31210928
http://dx.doi.org/10.1186/s13756-019-0549-8
_version_ 1783427087145631744
author Shafquat, Yusra
Jabeen, Kauser
Farooqi, Joveria
Mehmood, Kiran
Irfan, Seema
Hasan, Rumina
Zafar, Afia
author_facet Shafquat, Yusra
Jabeen, Kauser
Farooqi, Joveria
Mehmood, Kiran
Irfan, Seema
Hasan, Rumina
Zafar, Afia
author_sort Shafquat, Yusra
collection PubMed
description BACKGROUND: Globally metronidazole and carbapenem resistance in anaerobic organisms is increasing necessitating continuous surveillance to guide selection of empirical treatment. In this study we have determined metronidazole resistance in anaerobes using MIC Evaluator strips (M.I.C.E strips). Carbapenem resistance was evaluated only in metronidazole resistant isolates. MATERIAL AND METHODS: The study was conducted at the Aga Khan University (AKU) Hospital laboratory, Karachi, Pakistan (2014–2017). Metronidazole and imipenem resistance was evaluated using M.I.C.E strips and minimum inhibitory concentrations (MICs) were interpreted using Clinical Laboratory Standards Institute (CLSI) criteria. Clinical details including demographics, prolonged hospital stay, malignancy, transplant, dialysis, diabetes, site of infection and outcome were analyzed for association with metronidazole resistance. RESULTS: Of the 223 clinically significant isolates, 39 (17.5%) were metronidazole resistant (excluding the inherently resistant organisms; for example Cutibacterium species). Imipenem resistance was determined in 29 metronidazole resistant isolates and of these 7 (24.1%) were found to be resistant. Proportion of metronidazole resistant strains was highest amongst Bacteroides species. A significant increase in metronidazole resistance from 12.3% in 2010–2011 to 17.5% in the current study was found. Carbapenem resistance also emerged in the period 2014–2017. Isolates from malignancy and transplant patients showed lower odds of developing metronidazole resistance (0.003(95% CI: 1.7–17.9)). Prolonged hospital stay was not associated with metronidazole resistance (1.1((95% CI: 0.5–2.5)). CONCLUSION: The rising trend of metronidazole resistance and emergence of carbapenem resistance in anaerobic bacteria is alarming. Continued surveillance with strengthening of laboratory capacity regarding anaerobic susceptibility testing is urgently needed in Pakistan.
format Online
Article
Text
id pubmed-6567479
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65674792019-06-17 Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan Shafquat, Yusra Jabeen, Kauser Farooqi, Joveria Mehmood, Kiran Irfan, Seema Hasan, Rumina Zafar, Afia Antimicrob Resist Infect Control Research BACKGROUND: Globally metronidazole and carbapenem resistance in anaerobic organisms is increasing necessitating continuous surveillance to guide selection of empirical treatment. In this study we have determined metronidazole resistance in anaerobes using MIC Evaluator strips (M.I.C.E strips). Carbapenem resistance was evaluated only in metronidazole resistant isolates. MATERIAL AND METHODS: The study was conducted at the Aga Khan University (AKU) Hospital laboratory, Karachi, Pakistan (2014–2017). Metronidazole and imipenem resistance was evaluated using M.I.C.E strips and minimum inhibitory concentrations (MICs) were interpreted using Clinical Laboratory Standards Institute (CLSI) criteria. Clinical details including demographics, prolonged hospital stay, malignancy, transplant, dialysis, diabetes, site of infection and outcome were analyzed for association with metronidazole resistance. RESULTS: Of the 223 clinically significant isolates, 39 (17.5%) were metronidazole resistant (excluding the inherently resistant organisms; for example Cutibacterium species). Imipenem resistance was determined in 29 metronidazole resistant isolates and of these 7 (24.1%) were found to be resistant. Proportion of metronidazole resistant strains was highest amongst Bacteroides species. A significant increase in metronidazole resistance from 12.3% in 2010–2011 to 17.5% in the current study was found. Carbapenem resistance also emerged in the period 2014–2017. Isolates from malignancy and transplant patients showed lower odds of developing metronidazole resistance (0.003(95% CI: 1.7–17.9)). Prolonged hospital stay was not associated with metronidazole resistance (1.1((95% CI: 0.5–2.5)). CONCLUSION: The rising trend of metronidazole resistance and emergence of carbapenem resistance in anaerobic bacteria is alarming. Continued surveillance with strengthening of laboratory capacity regarding anaerobic susceptibility testing is urgently needed in Pakistan. BioMed Central 2019-06-14 /pmc/articles/PMC6567479/ /pubmed/31210928 http://dx.doi.org/10.1186/s13756-019-0549-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Shafquat, Yusra
Jabeen, Kauser
Farooqi, Joveria
Mehmood, Kiran
Irfan, Seema
Hasan, Rumina
Zafar, Afia
Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
title Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
title_full Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
title_fullStr Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
title_full_unstemmed Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
title_short Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
title_sort antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from pakistan
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567479/
https://www.ncbi.nlm.nih.gov/pubmed/31210928
http://dx.doi.org/10.1186/s13756-019-0549-8
work_keys_str_mv AT shafquatyusra antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan
AT jabeenkauser antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan
AT farooqijoveria antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan
AT mehmoodkiran antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan
AT irfanseema antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan
AT hasanrumina antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan
AT zafarafia antimicrobialsusceptibilityagainstmetronidazoleandcarbapeneminclinicalanaerobicisolatesfrompakistan